Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Favorite
Like
Email
Post
Print
Christopher L. Moore, PhD (he/him/his)
Director
GentiBio
Poster(s):
(710) An allogeneic CD19 targeted Engineered Treg approach for treating B cell mediated autoimmune diseases
Saturday, April 18, 2026
2:30 PM - 3:30 PM
US ET
Email Christopher